Literature DB >> 10710718

Chromatin control of HIV-1 gene expression.

G Marzio1, M Giacca.   

Abstract

Upon infection of susceptible cells, the RNA genome of the human immunodeficiency virus type 1 (HIV-1) is reverse transcribed into double-stranded DNA, which can be subsequently integrated into the cellular genome. After integration, the viral long terminal repeat (LTR) promoter is present in a nucleosome-bound conformation and is transcriptionally silent in the absence of stimulation. Activation of HIV-1 gene expression is concomitant with an acetylation-dependent rearrangement of the nucleosome positioned at the viral transcription start site. Thus, similar to most cellular genes, the transcriptional state of the integrated HIV-1 provirus is closely linked to histone acetylation. This enzymatic activity results from the function of histone-specific nuclear acetyltransferase (HAT) enzymes. Efficient viral transcription is strongly dependent on the virally-encoded Tat protein. the mechanism by which Tat increases the rate of transcriptional initiation has been recently demonstrated and involves the interaction of Tat with the transcriptional coactivator p300 and the closely related CREB-binding protein (CBP), having histone acetyltransferase activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10710718     DOI: 10.1023/a:1003797332379

Source DB:  PubMed          Journal:  Genetica        ISSN: 0016-6707            Impact factor:   1.082


  8 in total

1.  Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter.

Authors:  Marina Lusic; Alessandro Marcello; Anna Cereseto; Mauro Giacca
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

Review 2.  Innate and adaptive factors regulating human immunodeficiency virus type 1 genomic activation.

Authors:  Sonia Shah; Michael R Nonnemacher; Vanessa Pirrone; Brian Wigdahl
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-13       Impact factor: 4.147

3.  Calcium-dependent enhancement of transcription of p300 by human T-lymphotropic type 1 p12I.

Authors:  Amrithraj M Nair; Bindhu Michael; Antara Datta; Soledad Fernandez; Michael D Lairmore
Journal:  Virology       Date:  2006-07-14       Impact factor: 3.616

Review 4.  Epigenetics, drugs of abuse, and the retroviral promoter.

Authors:  Jasmine Shirazi; Sonia Shah; Divya Sagar; Michael R Nonnemacher; Brian Wigdahl; Zafar K Khan; Pooja Jain
Journal:  J Neuroimmune Pharmacol       Date:  2013-11-12       Impact factor: 4.147

5.  Bis-anthracycline antibiotics inhibit human immunodeficiency virus type 1 transcription.

Authors:  Olaf Kutsch; David N Levy; Paula J Bates; Julie Decker; Barry R Kosloff; George M Shaw; W Priebe; Etty N Benveniste
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

6.  BCL11B is a general transcriptional repressor of the HIV-1 long terminal repeat in T lymphocytes through recruitment of the NuRD complex.

Authors:  Valeriu B Cismasiu; Elena Paskaleva; Sneha Suman Daya; Mario Canki; Karen Duus; Dorina Avram
Journal:  Virology       Date:  2008-09-02       Impact factor: 3.616

7.  Adeno-associated virus type 2 rep protein inhibits human papillomavirus type 16 E2 recruitment of the transcriptional coactivator p300.

Authors:  A Marcello; P Massimi; L Banks; M Giacca
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

8.  HIV-1 Tat second exon limits the extent of Tat-mediated modulation of interferon-stimulated genes in antigen presenting cells.

Authors:  Sami Kukkonen; Maria Del Pilar Martinez-Viedma; Nayoung Kim; Mariana Manrique; Anna Aldovini
Journal:  Retrovirology       Date:  2014-04-17       Impact factor: 4.602

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.